Nota: La página que ha solicitado no está en su idioma predeterminado. Usted está usando nuestra plataforma en otro idioma ahora.

BARDA funding for the development of COVID-19 vaccines in the U.S. 2021

Published by
Matej Mikulic,
Oct 9, 2023
According to data as of March 2021, around six billion U.S. dollars were paid to Pfizer and BioNtech by the Biomedical Advanced Research and Development Authority of the United States to support the development of their COVID-19 vaccine. This statistic illustrates the BARDA funding for the development of select COVID-19 vaccines in the United States.

BARDA funding for the development of COVID-19 vaccines in the United States as of March 2021 (in million U.S. dollars)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

April 2021

Region

United States

Survey time period

as of March 2, 2021

Supplementary notes

BARDA: Biomedical Advanced Research and Development Authority
* NIAID: National Institute of Allergy and Infectious Diseases
** IAVI = International AIDS Vaccine Initiative

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Moderna Inc. "

The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Moderna Inc.

Market overview

6

Key figures

5

Competitors

4

Focus: COVID-19

8

Further related statistics

11

Further Content: You might find this interesting as well

Statistics

Topics

ModernaGlobal pharmaceutical industryPfizerBioNTechVaccinations in the U.S.
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.
Menu